Targeting CYP3A4 in oxidative metabolism has been reported to be an important strategy for enhancing the sensitivity of hepatocellular carcinoma cells to chemotherapeutic drugs (Figure 3E) (He et al., 2021; Özkan et al., 2021). The gene discussed is CYP3A4; the disease is hepatocellular carcinoma.